The American Society of Clinical Oncology (ASCO) is holding its 2013 Annual Meeting in Chicago, IL from May 31-June 4, 2013. "Building Bridges to Conquer Cancer" is the theme of this year's meeting which will bring more than 250,000 oncology professionals together.
Symptoms, Not Scans, Offer Better Measure of Relapse for DLBCL Patients
Imaging spotted relapses for just a tiny fraction of patients with diffuse large B-cell lymphoma (DLBCL) before symptoms appeared, according to a new multi-institutional study, prompting recommendations that the radiation exposure of follow-up scans may not be worthwhile for all patients.
Dr. Kolodziej Addresses the Impact of Payer Policy on the Use of Immunotherapy
Michael Kolodziej, MD, National Medical Director for Oncology Strategies, Aetna, says that in regard to payers impacting the use of immunotherapies, most payers have decided they will respect the judgment of the Food and Drug Administration, Centers for Medicare & Medicaid Services and the National Comprehensive Cancer Network.
Penn Survey Finds Cancer Drug Shortages Affect Treatment, Research
Ongoing shortages of common oncology chemotherapies have compelled physicians to substitute more expensive drugs, delay or suspend clinical trials, or even skip doses of chemotherapy, according to survey results gathered by a team from the University of Pennsylvania.